Skip to content

Clinical trials

Recruiting Phase 3 Hemorrhage trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 3 Status: Recruiting Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20192
20211
20223
20231
20242
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting19

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
London School of Hygiene and Tropical Medicine2
Montreal Heart Institute2
Pfizer2
Population Health Research Institute2
Regeneron Pharmaceuticals2
Takeda2
Corza Medical GmbH1
Fundacion Clinica Valle del Lili1
Grand Shuyang Life Sciences (Chengdu) Co., Ltd.1
Hamilton Health Sciences Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage19
Purpura, Thrombocytopenic, Idiopathic3
Atrial Fibrillation2
Autoimmune Diseases2
Blood Platelet Disorders2
Cytopenia2
Hematologic Diseases2
Hemophilia A2
Hemophilia B2
Hemorrhagic Disorders2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.